Phthalimides: developments in synthesis and functionalization
RSC Advances · 2024 · 14 (32) · 22809-22827
DOI: 10.1039/d4ra03859b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2024. Verfasst von Fatemeh Doraghi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran …. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Phthalimides are prevalent in pharmaceuticals, and natural products, etc . The synthesis of phthalimides catalyzed by transition metals and under metal-free conditions as well as functionalization of NH-phthalimides are described in this review.
Autor:innen und Institutionen
- Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
- School of Chemistry, College of Science, University of Tehran Tehran Iran.
- Department of Chemistry, Faculty of Education, Ghazni University Ghazni Afghanistan.
ORCID-Profile: Fatemeh Doraghi, Mohammad Mahdavi
Zitieren
APA
Doraghi, F., Morshedsolouk, M. H., Zahedi, N. A., Larijani, B., & Mahdavi, M. (2024). Phthalimides: developments in synthesis and functionalization. RSC Advances, 14(32), 22809-22827. https://doi.org/10.1039/d4ra03859b
Vancouver
Doraghi F, Morshedsolouk MH, Zahedi NA, Larijani B, Mahdavi M. Phthalimides: developments in synthesis and functionalization. RSC Advances. 2024;14(32):22809-22827. doi:10.1039/d4ra03859b
BibTeX
@article{Doraghi2024,
author = {Doraghi, Fatemeh and Morshedsolouk, Mohammad Hossein and Zahedi, Nawrooz Ali and Larijani, Bagher and Mahdavi, Mohammad},
title = {Phthalimides: developments in synthesis and functionalization},
journal = {RSC Advances},
year = {2024},
volume = {14},
number = {32},
pages = {22809--22827},
doi = {10.1039/d4ra03859b}
}
EUVIMED